Image

Effect of Remote Ischemic Conditioning on Cerebral Hemodynamics in Patients After Intravenous Thrombolysis (RICCH-IVT)

Recruiting
18 - 80 years of age
Both
Phase N/A

Powered by AI

Overview

The purpose of this study is to determine the effect of remote ischemic conditioning on cerebral hemodynamics in patients after intravenous thrombolysis

Description

In this study, cases of ischemic stroke who undergo intravenous thrombolysis within 4.5 hours from onset are included. The RIC group receive basic treatment and remote ischemic conditioning for 200mmHg at 6 and 18-24 hours after intravenous thrombolysis. The sham-RIC group receive basic treatment and remote ischemic conditioning for 60mmHg at 6 and 18-24 hours after intravenous thrombolysis. Both groups underwent cerebral hemodynamics after RIC and recorded the relevant indexes. The investigators aimed to determine the effect of remote ischemic conditioning on cerebral hemodynamics in patients after intravenous thrombolysis.

Eligibility

Inclusion Criteria:

  1. age ≥ 18 and < 80 years, both sexes;
  2. a clear clinical diagnosis of acute ischemic stroke and treatment with standard rt-PA (0.9 mg/kg) IVT within 4.5 h of stroke onset;
  3. pre-onset modified Rankin Scale (mRS) score ≤1;
  4. baseline National Institute of Health Stroke Scale (NIHSS) score ≥5 and ≤25;
  5. Glasgow Coma Scale score ≥8.

Exclusion Criteria:

  1. having received bridging therapy (IVT plus mechanical thrombectomy);
  2. previous history of atrial fibrillation or electrocardiographic evidence of atrial fibrillation;
  3. contraindications to RIC treatment or previous RIC treatment or similar treatment;
  4. pregnancy or breastfeeding;
  5. life expectancy of ≤3 months or inability to complete the study for other reasons;
  6. unwillingness to be followed up or poor treatment compliance or participation in other clinical studies;
  7. had insufficient bilateral temporal bone windows for insonation of the middle cerebral artery.

Study details

Remote Ischemic Conditioning

NCT05598658

Yi Yang

7 March 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.